TABLE 2.
Patient details and demographics
| IDs | Age at injury (years) | Sex | Number of usable EEG observations | Mean GCS | GOSe | Time to follow up (days) | Included in fMRI analysis? | Comments |
|---|---|---|---|---|---|---|---|---|
| 1 | 19 | Male | 9 | 10 | 7 | 181 | No | |
| 2 | 20 | Female | 4 | 4 | 3 | 192 | Yes | |
| 3 | 20 | Male | 2 | 7 | 6 | 170 | No | Excluded from LMMs due to insufficient number of observations |
| 4 | 22 | Male | 9 | 7 | 6 | 179 | No | EEG recorded with Moberg ICU solutions |
| 5 | 22 | Male | 7 | 6 | 3 | 164 | No | |
| 6 | 22 | Male | 1 | 10 | 4 | 158 | Yes | Excluded from LMMs due to insufficient number of observations |
| 7 | 22 | Male | 1 | 13 | 8 | 184 | No | Excluded from LMMs due to insufficient number of observations |
| 8 | 23 | Female | 12 | 7 | 7 | 182 | Yes | Excluded from non‐fMRI analyses due to missing medication data |
| 9 | 23 | Female | 3 | 7 | 3 | 183 | Yes | |
| 10 | 25 | Male | 11 | 3 | 8 | 180 | Yes | |
| 11 | 26 | Male | 14 | 3 | 2 | 161 | No | |
| 12 | 27 | Male | 3 | 10 | 7 | 179 | No | |
| 13 | 28 | Male | 13 | 8 | 4 | 177 | No | |
| 14 | 31 | Male | 15 | 3 | 3 | 246 | Yes | |
| 15 | 31 | Male | 13 | 7 | 6 | 182 | No | |
| 16 | 31 | Male | 13 | 4 | 3 | 183 | No | |
| 17 | 32 | Male | 8 | 6 | 3 | 177 | No | |
| 18 | 33 | Male | 11 | 6 | N/A | N/A | Yes | Excluded from prediction of chronic outcome (missing GOSe score) |
| 19 | 36 | Female | 9 | 6 | 7 | 188 | No | |
| 20 | 37 | Male | 8 | 4 | 2 | 177 | No | |
| 21 | 39 | Male | 12 | 7 | 3 | 179 | Yes | |
| 22 | 40 | Male | 2 | 10 | 5 | 173 | No | Excluded from LMMs due to insufficient number of observations |
| 23 | 43 | Male | 4 | 7 | 5 | 203 | No | |
| 24 | 44 | Male | 12 | 11 | 2 | 172 | No | |
| 25 | 45 | Male | 9 | 10 | 3 | 182 | No | |
| 26 | 47 | Male | 4 | 8 | 5 | 184 | No | EEG recorded with Moberg ICU solutions |
| 27 | 49 | Male | 6 | 14 | 6 | 174 | No | |
| 28 | 54 | Male | 9 | 8 | 5 | 189 | No | |
| 29 | 55 | Male | 15 | 7 | N/A | N/A | No | Excluded from prediction of chronic outcome (missing GOSe score) |
| 30 | 55 | Female | 13 | 14 | N/A | N/A | Yes | Excluded from prediction of chronic outcome (missing GOSe score) |
| 31 | 57 | Male | 11 | 7 | 3 | 224 | Yes | |
| 32 | 58 | Female | 11 | 9 | 1 | N/A | No | Patient deceased |
| 33 | 59 | Male | 16 | 6 | 3 | 279 | Yes | |
| 34 | 61 | Male | 4 | 8 | 7 | 318 | No | |
| 35 | 62 | Female | 8 | 10 | 3 | 181 | No | |
| 36 | 72 | Male | 6 | 14 | 6 | 182 | No | |
| 37 | 75 | Male | 8 | 7 | N/A | N/A | No | Excluded from prediction of chronic outcome (missing GOSe score) |
| 38 | 84 | Male | 4 | 7 | 5 | 177 | No |
Note: Our heavily male sample reflects higher risk for TBI in males. “Time to follow up” gives the number of days postinjury when GOSe assessments were performed. Note that GOSe = 1 indicates that the patient was deceased (thus, for Patient 32, the time to follow up was not applicable). Comments give additional details including which analyses, if any, patients were excluded from and why.
Abbreviation: N/A, not applicable.